CD26 and Cancer

Oscar J Cordero^{1

2

3}

Affiliations

¹ Department of Biochemistry and Molecular Biology, CIBUS Building, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
² Gene Regulatory Control in Disease Group, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
³ Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.

PMID: 36358613
PMCID: PMC9655702
DOI: 10.3390/cancers14215194

Editorial

CD26 and Cancer

Oscar J Cordero. Cancers (Basel). 2022.

. 2022 Oct 23;14(21):5194.

doi: 10.3390/cancers14215194.

Author

Oscar J Cordero^{1

2

3}

Affiliations

¹ Department of Biochemistry and Molecular Biology, CIBUS Building, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
² Gene Regulatory Control in Disease Group, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
³ Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.

PMID: 36358613
PMCID: PMC9655702
DOI: 10.3390/cancers14215194

Abstract

This Special Issue presents new knowledge on the complex behaviour of dipeptidyl peptidase 4 (DPP4, EC 3 [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Cited by

The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive.
Kast RE. Kast RE. Int J Mol Sci. 2023 Oct 23;24(20):15474. doi: 10.3390/ijms242015474. Int J Mol Sci. 2023. PMID: 37895152 Free PMC article. Review.
Comment on Lai et al. Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells. Int. J. Mol. Sci. 2023, 24, 16101.
Cordero OJ, Kotrulev M, Gomez-Touriño I. Cordero OJ, et al. Int J Mol Sci. 2024 Jun 28;25(13):7093. doi: 10.3390/ijms25137093. Int J Mol Sci. 2024. PMID: 39000199 Free PMC article.
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma.
Rossetti A, Chonco L, Alegría N, Zelli V, García AJ, Ramírez-Castillejo C, Tessitore A, de Cabo C, Landete-Castillejos T, Festuccia C. Rossetti A, et al. Pharmaceutics. 2024 Apr 30;16(5):610. doi: 10.3390/pharmaceutics16050610. Pharmaceutics. 2024. PMID: 38794272 Free PMC article.
Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy.
Kotrulev M, Gomez-Touriño I, Cordero OJ. Kotrulev M, et al. Cancers (Basel). 2024 Jun 30;16(13):2427. doi: 10.3390/cancers16132427. Cancers (Basel). 2024. PMID: 39001488 Free PMC article. Review.
Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcoma.
Yen CC, Chen PC, Chen SC, Wu WC, Yen CH, Lin YC, Wu PK, Chen CM, Wang JY, Chao TC, Yang MH, Fletcher JA. Yen CC, et al. Oncol Lett. 2025 Apr 7;29(6):269. doi: 10.3892/ol.2025.15015. eCollection 2025 Jun. Oncol Lett. 2025. PMID: 40247991 Free PMC article.

References

1. Hopsu-Havu V.K., Glenner G.G. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie. 1966;7:197–201. doi: 10.1007/BF00577838. - DOI - PubMed
1. Schrader W.P., Stacy A.R. Purification and subunit structure of adenosine deaminase from human kidney. J. Biol. Chem. 1977;252:6409–6415. doi: 10.1016/S0021-9258(17)39973-8. - DOI - PubMed
1. Trotta P.P., Balis M.E. Characterization of adenosine deaminase from normal colon and colon tumors. Evidence for tumor specific variants. Biochemistry. 1978;77:270–278. doi: 10.1021/bi00595a013. - DOI - PubMed
1. Ten Kate J., van den Ingh H.F., Khan P.M., Bosman F.T. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. Int. J. Cancer. 1986;37:479–485. doi: 10.1002/ijc.2910370402. - DOI - PubMed
1. Fox D.A., Hussey R.E., Fitzgerald K.A., Acuto O., Poole C., Palley L., Daley J.F., Schlossman S.F., Reinherz E.L. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J. Immunol. 1984;133:1250–1256. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

CD26 and Cancer

Affiliations

CD26 and Cancer

Author

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous